Enzymotec | Development and Marketing of Innovative BioFunctional Products
`NOV SEP DEC
`
`http://www.enzymotec.com/PageIndex.asp?cc=01020403
`
`Go
`
`13 captures
`11 Mar 2006 - 9 Jun 2010
`
`Home
`
`About Us
`
`Products
`
`Markets
`
`R&D;
`
`Quality
`
`News & Events
`
`Contact Us
`
`CardiaBeat™ won NutrAward
`2007
`[03,2007] Enzymotec is pleased
`to announce that CardiaBeat™
`won the NutrAward prize at the
`SupplyExpo 2007. Criteria for
`choosing CardiaBeatTM
`included its efficacy, safety,
`innovativeness, scientific merit
`and market potential. more
`R&D; investments in 2007
`[12,2006] Yesterday morning,
`the company announced its
`R&D; expenditure plan for 2007,
`which will reach $3.5M. more
`Sharp●PS™ GOLD winner
`NBJ 2007
`[06,2007] Enzymotec
`announced today that
`Sharp●PS™ GOLD is one of the
`recipients of NBJ's product merit
`award for 2007 The formal
`opening of an active web-site:
`www.Sharp-PS.com, was also
`announced. more
`
`
`
`
`
`2006 2007 2009
`
`search
`
`
`
`Products
`
`CardiaBeatTM for
`Foods
`
`CardiaBeatTM for
`Supplements
`
`Plant sterol-based matrix featuring a better pro-heart effect.
`
`Novel, lipid-based ingredient offering Total Lipid Control.
`
`Krill Oil
`
`A propreitary complex of Krill oil.
`
`Sharp•PSTM
`
`Phosphatidylserine (PS) for Dietary supplements & Functional
`foods. PS is beneficial for memory loss conditions, cognitive
`performance, improving mood and learning abilities.
`
`Sharp●PSTM SILVER
`
`Highly concentrated blend of Phosphatidylserine with DHA for
`dietary supplements, which can improve mental and cognitive
`abilities.
`
`Sharp●PS TM GOLD
`
`An exclusive phosphatidilserine-Omega-3 conjugated compound
`enriched with LC-PUFA (Long Chain Poly Unsaturated Fatty Acids)
`for dietary supplements.
`
`SharpGPCTM
`
`A high quality alpha-Glycerol PhosphatidylCholine (GPC) for
`boosting acethylCholine levels and improving cognitive condition.
`
`InFatTM
`
`Improving Calcium and energy absorption in infant formulas.
`
`InPUFATM
`
`Mimicking mother's milk ability to boost DHA availability into the
`brain.
`
`⍰❎
`f 🐦
`
`▾ About this capture
`
`25
`
`7/6/2017
`
`https://web.archive.org/web/20070925024350/http://www.enzymotec.com/PageIndex.asp?cc=01020403
`
`©2005 Enzymotec Corporation. All rights reserved.
`read our Terms of Use & Limited Liability Statements.
`
`RIMFROST EXHIBIT 1060 page 0001
`
`1/2
`
`

`

`7/6/2017
`
`Enzymotec | Development and Marketing of Innovative BioFunctional Products
`
`https://web.archive.org/web/20070925024350/http://www.enzymotec.com/PageIndex.asp?cc=01020403
`
`RIMFROST EXHIBIT 1060 page 0002
`
`2/2
`
`

`

`Enzymotec | Development and Marketing of Innovative BioFunctional Products
`NOV SEP DEC
`
`http://www.enzymotec.com/Page.asp?cc=01020408
`
`Go
`
`2006 2007 2009
`
`search
`
`
`
`R&D Strategy
`
`Enzymotec develops a variety of unique and cost-effective lipid-
`based ingredients for functional food and dietary supplements.
`In order to ensure a continuous streamline of novel ingredients, Enzymotec is
`active in various development areas as listed below.
`
`
`
`Clinical trials
`Enzymotec's advanced products are backed by clinical trials performed by
`leading scientists at internationally-renowned institutes, both in Israel and
`abroad.
`
`Regulatory activity
`An essential part of product development is to ensure the legal/regulatory status
`of the ingredients. Enzymotec is globally active in its efforts to ensure GRAS,
`NDI, Novel food or any other legal status required for the marketing and
`distribution of the ingredients in various geographical areas.
`
`IP strategy
`Enzymotec defends its IP position by creating clusters of patents, which cover
`process, composition, health benefits and potential applications for its
`various products.
`
`Processing Technology
`One of Enzymotec's key advantages is its capacity to harness advanced
`processing tools and processing aids.
`
`Analytical tools
`Enzymotec uses state-of-the-art methods and tools, including: HPLC, HPTLC,
`GC or NMR to ensure the quality of its product and the satsifaction of its
`customers.
`
`
`
`13 captures
`11 Mar 2006 - 9 Jun 2010
`
`Home
`
`About Us
`
`Products
`
`Markets
`
`R&D;
`
`Quality
`
`News & Events
`
`Contact Us
`
`R&D;
`
`
`
`
`
`Enzymotec takes
`advantage of its
`technology platform to
`biocatalytically
`structure, synthesize,
`and enrich
`phospholipids,
`triglycerides and
`phytosterols
`
`
`
`
`CardiaBeat™ won NutrAward
`2007
`[03,2007] Enzymotec is pleased
`to announce that CardiaBeat™
`won the NutrAward prize at the
`SupplyExpo 2007. Criteria for
`choosing CardiaBeatTM included
`its efficacy, safety, innovativeness,
`scientific merit and market
`potential. more
`R&D; investments in 2007
`[12,2006] Yesterday morning, the
`company announced its R&D;
`expenditure plan for 2007, which
`will reach $3.5M. more
`Sharp●PS™ GOLD winner NBJ
`2007
`[06,2007] Enzymotec announced
`today that Sharp●PS™ GOLD is
`one of the recipients of NBJ's
`product merit award for 2007 The
`formal opening of an active web-
`site: www.Sharp-PS.com, was
`also announced. more
`
`
`
`⍰❎
`f 🐦
`
`▾ About this capture
`
`25
`
`7/6/2017
`
`©2005 Enzymotec Corporation. All rights reserved.
`read our Terms of Use & Limited Liability Statements.
`
`https://web.archive.org/web/20070925024521/http://www.enzymotec.com/Page.asp?cc=01020408
`
`RIMFROST EXHIBIT 1060 page 0003
`
`1/1
`
`